FOA
Five Oceans Advisors Portfolio holdings
AUM
$234M
This Quarter Return
+9.75%
1 Year Return
+16.64%
3 Year Return
+62.1%
5 Year Return
–
10 Year Return
–
AUM
$179M
AUM Growth
+$179M
(+15%)
Cap. Flow
+$9.71M
Cap. Flow
% of AUM
5.43%
Top 10 Holdings %
Top 10 Hldgs %
45.81%
Holding
174
New
26
Increased
52
Reduced
76
Closed
1
Top Buys
Top Sells
| 1 |
Novo Nordisk
NVO
|
$367K |
| 2 |
Dimensional US Small Cap Value ETF
DFSV
|
$246K |
| 3 |
JPMorgan Chase
JPM
|
$222K |
| 4 |
Dimensional International Value ETF
DFIV
|
$163K |
| 5 |
Dimensional International Small Cap ETF
DFIS
|
$158K |
Sector Composition
| 1 | Technology | 11.28% |
| 2 | Healthcare | 6.36% |
| 3 | Financials | 5.67% |
| 4 | Communication Services | 5.21% |
| 5 | Consumer Discretionary | 4.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Walt Disney
DIS
$213B
| $258K | 0.14% |
2,852
+307
| +12% | +$27.7K |
|
127
Dimensional Global Real Estate ETF
DFGR
$2.65B
| $257K | 0.14% |
+9,892
| New | +$257K |
|
128
Intuit
INTU
$185B
| $257K | 0.14% |
411
-1
| -0.2% | -$625 |
|
129
Blackrock
BLK
$173B
| $253K | 0.14% |
312
-9
| -3% | -$7.31K |
|
130
Danaher
DHR
$146B
| $247K | 0.14% |
1,067
-32
| -3% | -$7.4K |
|
131
Regeneron Pharmaceuticals
REGN
$61.2B
| $247K | 0.14% |
281
-7
| -2% | -$6.15K |
|
132
Aflac
AFL
$56.5B
| $246K | 0.14% |
2,987
+22
| +0.7% | +$1.82K |
|
133
Bank of America
BAC
$373B
| $246K | 0.14% |
+7,314
| New | +$246K |
|
134
Ameriprise Financial
AMP
$48.3B
| $241K | 0.13% |
634
-3
| -0.5% | -$1.14K |
|
135
Pultegroup
PHM
$26.1B
| $237K | 0.13% |
+2,295
| New | +$237K |
|
136
KLA
KLAC
$112B
| $235K | 0.13% |
+405
| New | +$235K |
|
137
Sanofi
SNY
$121B
| $235K | 0.13% |
+4,733
| New | +$235K |
|
138
Marathon Petroleum
MPC
$54.8B
| $235K | 0.13% |
1,584
-147
| -8% | -$21.8K |
|
139
iShares Core MSCI International Developed Markets ETF
IDEV
$21B
| $232K | 0.13% |
3,648
| – | – |
|
140
ING
ING
$70.6B
| $232K | 0.13% |
15,457
| – | – |
|
141
PACCAR
PCAR
$51.9B
| $232K | 0.13% |
2,371
-26
| -1% | -$2.54K |
|
142
W.W. Grainger
GWW
$48.6B
| $231K | 0.13% |
+279
| New | +$231K |
|
143
Vertex Pharmaceuticals
VRTX
$103B
| $230K | 0.13% |
+565
| New | +$230K |
|
144
RTX Corp
RTX
$211B
| $228K | 0.13% |
+2,708
| New | +$228K |
|
145
S&P Global
SPGI
$165B
| $228K | 0.13% |
+517
| New | +$228K |
|
146
Progressive
PGR
$144B
| $225K | 0.13% |
+1,414
| New | +$225K |
|
147
Takeda Pharmaceutical
TAK
$47.8B
| $224K | 0.13% |
15,720
-2,708
| -15% | -$38.6K |
|
148
Eaton
ETN
$134B
| $224K | 0.13% |
+930
| New | +$224K |
|
149
Target
TGT
$42B
| $221K | 0.12% |
+1,552
| New | +$221K |
|
150
Linde
LIN
$222B
| $218K | 0.12% |
+530
| New | +$218K |
|